- Johnson & Johnson said it plans to pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.
- The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
- J&J said the remaining pending lawsuits relate to a rare cancer called mesothelioma and will be addressed outside of the new settlement plan.
Also, according to https://www.lawsuit-information-center.com/2-billion-verdict-in-missouri-motivates-jj-to-settle-talcum-powder-lawsuits.html:
This settlement deal only covers the talcum powder claims involving ovarian cancer. J&J has already settled 95% of the talcum power claims involving mesothelioma.
Looks like the talc lawsuits are finally wrapping up? These have kept me on the JNJ sidelines. Any general thoughts on JNJ? It's up 4% on the day from this news.
Leave a Reply